What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
His scientific interests lie mostly in Psychiatry, Internal medicine, Depression, Major depressive disorder and Endocrinology.
His studies link Clinical psychology with Psychiatry.
His work investigates the relationship between Internal medicine and topics such as Placebo that intersect with problems in Anesthesia.
His Depression study deals with Psychosis intersecting with Schizophrenia and Bipolar disorder.
Alan F. Schatzberg works mostly in the field of Major depressive disorder, limiting it down to topics relating to Nefazodone and, in certain cases, Cognitive behavioral therapy, Psychotherapist and Cognitive therapy.
His Hydrocortisone research integrates issues from Central nervous system, Neuroscience and Adrenocorticotropic hormone.
His most cited work include:
- Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control (4533 citations)
- Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus (1647 citations)
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (1570 citations)
What are the main themes of his work throughout his whole career to date?
Psychiatry, Internal medicine, Depression, Endocrinology and Clinical psychology are his primary areas of study.
His Psychiatry and Major depressive disorder, Antidepressant, Bipolar disorder, Anxiety and Sertraline investigations all form part of his Psychiatry research activities.
His research integrates issues of Schizophrenia and Mood disorders in his study of Bipolar disorder.
His Internal medicine research focuses on Placebo and how it connects with Anesthesia.
His Depression study incorporates themes from Psychotherapist and Psychosis.
He regularly links together related areas like Platelet in his Endocrinology studies.
He most often published in these fields:
- Psychiatry (34.47%)
- Internal medicine (37.38%)
- Depression (28.96%)
What were the highlights of his more recent work (between 2014-2021)?
- Depression (28.96%)
- Psychiatry (34.47%)
- Major depressive disorder (11.81%)
In recent papers he was focusing on the following fields of study:
Alan F. Schatzberg focuses on Depression, Psychiatry, Major depressive disorder, Internal medicine and Clinical psychology.
The study incorporates disciplines such as Neuromodulation, Functional magnetic resonance imaging, Prefrontal cortex and Transcranial magnetic stimulation in addition to Depression.
His Disease research extends to the thematically linked field of Psychiatry.
His Major depressive disorder research includes elements of Escitalopram, Dorsolateral prefrontal cortex, Human brain and Sertraline.
His study explores the link between Internal medicine and topics such as Antidepressant that cross with problems in Ketamine.
His studies in Clinical psychology integrate themes in fields like Randomized controlled trial and Cognition.
Between 2014 and 2021, his most popular works were:
- Resting-state connectivity biomarkers define neurophysiological subtypes of depression (885 citations)
- Genome-wide association study identifies 30 loci associated with bipolar disorder (518 citations)
- Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (518 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
Alan F. Schatzberg mainly investigates Major depressive disorder, Psychiatry, Depression, Internal medicine and Clinical psychology.
His Major depressive disorder study integrates concerns from other disciplines, such as Bipolar disorder, Schizophrenia, Randomized controlled trial and Human brain.
Alan F. Schatzberg combines subjects such as Off-label use and Disease with his study of Psychiatry.
He has included themes like Ketamine, Left superior frontal gyrus, Functional magnetic resonance imaging and Genotype in his Depression study.
His work focuses on many connections between Internal medicine and other disciplines, such as Mifepristone, that overlap with his field of interest in Psychotic depression and Glucocorticoid receptor.
His study looks at the intersection of Clinical psychology and topics like Cognition with Psychosis, Clinical trial and Neuroplasticity.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
